CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 30 09:13 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 30 09:09 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 30 09:06 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 29 10:09 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 29 10:07 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 29 10:05 ET
CANSINOBIO: 2023 Environmental, Social and Governance & Corporate Social Responsibility Report
Apr 24 09:07 ET
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED OBTAINS CLINICAL TRIAL APPROVAL
Apr 22 06:55 ET
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - POSITIVE PRELIMINARY PHASE I CLINICAL RESULTS FOR PROTEIN-BASED PNEUMOCOCCAL VACCINE
Apr 21 06:19 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 11 07:34 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 11 07:29 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 11 07:24 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 3 05:35 ET
CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities
Apr 2 23:15 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Mar 27 10:49 ET
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR ABSORBED TETANUS VACCINE
Mar 20 05:25 ET
CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Mar 13 10:43 ET
CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities
Mar 1 04:29 ET
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF DRUG REGISTRATION APPLICATION FOR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (CRM197, TT VECTOR)
Feb 28 04:32 ET
CANSINOBIO: List of Directors and their Roles and Functions
Feb 23 07:35 ET
No Data
No Data